Cingulate (CING) EPS (Diluted) (QoQ) (2022 - 2025)
Cingulate (CING) EPS (Diluted) (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Cingulate | 72.00 Mn | 72.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.78% |
| Mar 31, 2025 | 75.94% |
| Dec 31, 2024 | -86.60% |
| Sep 30, 2024 | 57.20% |
| Jun 30, 2024 | 11.01% |
| Mar 31, 2024 | 93.34% |
| Dec 31, 2023 | -26.66% |
| Sep 30, 2023 | 36.07% |
| Jun 30, 2023 | -33.60% |
| Mar 31, 2023 | 7.30% |
| Dec 31, 2022 | -28.28% |
| Sep 30, 2022 | 0.33% |